Trials / Completed
CompletedNCT01748539
A Phase 2 Clinical Study of KHK4827
A Randomized, Double-blind, Placebo-controlled Parallel Group Study in Subjects With Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the efficacy and safety of KHK4827 in subjects with moderate to severe plaque psoriasis in a randomized, double-blind, placebo-controlled, parallel group study. Pharmacokinetics of KHK4827 will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHK4827 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2012-12-12
- Last updated
- 2013-09-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01748539. Inclusion in this directory is not an endorsement.